Effect of heparin on APP metabolism and Aβ production in cortical neurons

Neurodegenerative Diseases

Volumn 7, Issue 1-3, 2010, Pages 187-189

  Klaver, David ^a,c   Hung, Amos C ^a   Gasperini, Robert ^a   Foa, Lisa ^a,b   Aguilar, Marie Isabel ^c   Small, David H ^a,c  

^a UNIVERSITY OF TASMANIA   (Australia)

^b UNIVERSITY OF TASMANIA   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Amyloid; Autocatalysis; Glycosaminoglycan; Heparin; Secretase

Indexed keywords

AMYLOID BETA PROTEIN; BETA SECRETASE; BETA SECRETASE 1; GLYCOSAMINOGLYCAN; HEPARIN; PROTEOGLYCAN;

BRAIN CELL; CONFERENCE PAPER; DRUG EFFECT; DRUG INHIBITION; HUMAN; PRIORITY JOURNAL;

AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ANIMALS, NEWBORN; ASPARTIC ACID ENDOPEPTIDASES; CELLS, CULTURED; CEREBRAL CORTEX; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBRINOLYTIC AGENTS; GENE EXPRESSION REGULATION; HEPARIN; HUMANS; MICE; MICE, TRANSGENIC; NEURONS;

EID: 77953559064     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000295661     Document Type: Conference Paper

References (10)

1. Cole SL, Vassar R: The role of amyloid precursor protein processing by BACE1, the β- secretase, in Alzheimer disease pathophysiology. J Biol Chem 2008; 283: 29621-29625.
2. Silvestri R: Boom in the development of nonpeptidic β-secretase (BACE1) inhibitors for the treatment of Alzheimer's disease. Med Res Rev 2009; 29: 295-338.
3. Scholefield Z, Yates EA, Wayne G, Amour A, McDowell W, Turnbull JE: Heparan sulfate regulates amyloid precursor protein processing by BACE1, the Alzheimer's β-secretase. J Cell Biol 2003; 163: 97-107.
4. Patey SJ, Edwards EA, Yates EA, Turnbull JE: Heparin derivatives as inhibitors of BACE-1, the Alzheimer's β-secretase, with reduced activity against factor Xa and other proteases. J Med Chem 2006; 49: 6129-6132.
5. Leveugle B, Ding W, Laurence F, Dehouck MP, Scanameo A, Cecchelli R, Fillit H: Heparin oligosaccharides that pass the bloodbrain barrier inhibit β-amyloid precursor protein secretion and heparin binding to β- amyloid peptide. J Neurochem 1998; 70: 736-744.
6. Bergamaschini L, Rossi E, Storini C, Pizzimenti S, Distaso M, Perego C, De Luigi A, Vergani C, De Simoni MG: Peripheral treatment with enoxaparin, a low molecular weight heparin, reduces plaques and β-amyloid accumulation in a mouse model of Alzheimer's disease. J Neurosci 2004; 24: 4181-4186.
7. Beckman M, Holsinger RM, Small DH: Heparin activates β-secretase (BACE1) of Alzheimer's disease and increases autocatalysis of the enzyme. Biochemistry 2006; 45: 6703-6714.
8. Leveugle B, Ding W, Durkin JT, Mistretta S, Eisle J, Matic M, Siman R, Greenberg BD, Fillit HM: Heparin promotes β-secretase cleavage of the Alzheimer's amyloid precursor protein. Neurochem Int 1997; 30: 543-548.
9. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G: Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 1996; 274: 99-102.
10. Savage MJ, Trusko SP, Howland DS, Pinsker LR, Mistretta S, Reaume AG, Greenberg BD, Siman R, Scott RW: Turnover of amyloid β- protein in mouse brain and acute reduction of its level by phorbol ester. J Neurosci 1998; 18: 1743-1752.